Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Tuberculosis and Respiratory Diseases|September 29, 2024
Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid CulturesHyeon Kyu Choi, Gaeul Bang, Ju Hye Shin, et al.Lung Cancer (Amsterdam, Netherlands)|January 28, 2014
Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaMin Hwan Kim, Hyo Sup Shim, Dae Ryong Kang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancerHye Ryun Kim, Dae Joon Kim, Dae Ryong Kang, et al.Yonsei Medical Journal|August 1, 2020
Identification of Fungal Species and Detection of Azole-Resistance Mutations in the <i>Aspergillus fumigatus cyp51A</i> Gene at a South Korean HospitalIn Young Jung, Youn Jung Lee, Hyo Sup Shim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2020
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung CancerMi Ran Yun, Dong Hwi Kim, Seok-Young Kim, et al.EMBO Molecular Medicine|October 22, 2019
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancerMi Ran Yun, Hun Mi Choi, You Won Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 RearrangementSun Min Lim, Hye Ryun Kim, Jong-Seok Lee, et al.European Journal of Cancer (Oxford, England : 1990)|December 10, 2020
Dynamic changes in circulating PD-1<sup>+</sup>CD8<sup>+</sup> T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancerChang Gon Kim, Min Hee Hong, Kyung Hwan Kim, et al.Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.Cancer Research|April 20, 2018
Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK InhibitorsMi Ran Yun, Sun Min Lim, Seon-Kyu Kim, et al.Pageof 14